Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Frontiers in Immunology|May 27, 2014
Indirectly Recognized HLA-C Mismatches and Their Potential Role in Transplant OutcomeKirsten A Thus, Liane Te Boome, Jürgen Kuball, et al.
Current Opinion in Ophthalmology|August 24, 2010
Current insights into ocular graft-versus-host diseaseAnjo Riemens, Liane te Boome, Saskia Imhof, et al.
Ocular Immunology and Inflammation|October 10, 2013
Absence of intraocular infections after hematopoietic stem cell transplantation at a single center: the experience with current preventive regimensElena I Stoyanova, Anjo Riemens, Henk M Lokhorst, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 2, 2014
Refinement of the definition of permissible HLA-DPB1 mismatches with predicted indirectly recognizable HLA-DPB1 epitopesKirsten A Thus, Mieke T A Ruizendaal, Talitha A de Hoop, et al.
Bone Marrow Transplantation|March 18, 2018
Prospective evaluation of sequential treatment of sclerotic chronic graft versus host disease with rituximab and nilotinibLotte van der Wagen, Liane Te Boome, Marleen Schiffler, et al.
Haematologica|May 7, 2011
The immunological phenotype of rituximab-sensitive chronic graft-versus-host disease: a phase II studySuzanne van Dorp, Henrike Resemann, Liane te Boome, et al.
The American Journal of Medicine|January 11, 2005
Mortality in systemic sclerosis: an international meta-analysis of individual patient dataJohn P A Ioannidis, Panayiotis G Vlachoyiannopoulos, Anna-Bettina Haidich, et al.
The Lancet. Haematology|May 2, 2026
Very early [18F]FDG-PET-guided targeted therapy in untreated advanced-stage classic Hodgkin lymphoma (EORTC-1537-COBRA): primary results of a single-arm, multicentre, phase 2 trialMartin Hutchings, Arjan Diepstra, Anna Sureda Balari, et al.
Blood Advances|September 3, 2021
Frequent mutated B2M, EZH2, IRF8, and TNFRSF14 in primary bone diffuse large B-cell lymphoma reflect a GCB phenotypeRuben A L de Groen, Ronald van Eijk, Stefan Böhringer, et al.
Blood Cancer Journal|April 29, 2025
Superior survival in diffuse large B cell lymphoma of the bone with immune rich tumor microenvironmentRuben A L de Groen, Fleur A de Groot, Stefan Böhringer, et al.
Pageof 1